{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-25-005919","form_type":"8-K","ticker":"EBRCZ","cik":"0001347123","company_name":"EBR Systems, Inc.","filed_at":"2025-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.039170+00:00","generated_at":"2026-05-23T14:20:50.593725+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CMS proposes NTAP reimbursement for EBR's WiSE CRT at max 65% rate","bullets":["CMS proposed NTAP for WiSE CRT System for FY 2026 at maximum add-on payment of 65% of device cost.","NTAP is in addition to standard MS-DRG payment, intended to fully cover device cost.","NTAP effective from 1 Oct 2025 for three years, subject to final CMS rule expected August 2025.","EBR plans to apply for Transitional Pass-through reimbursement for outpatients shortly.","FDA approval of WiSE CRT also announced; both milestones advance US commercialization."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-25-005919","json":"https://secwatch.observer/filing/0001214659-25-005919.json","markdown":"https://secwatch.observer/filing/0001214659-25-005919.md","text":"https://secwatch.observer/filing/0001214659-25-005919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347123/000121465925005919/0001214659-25-005919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347123/000121465925005919/z4152508k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T14:20:50.593725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}